PEDIATRICS Vol. 92 No. 3 September 1993, pp. 431-435
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pourcyrous, M.
Right arrow Articles by Wong, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pourcyrous, M.
Right arrow Articles by Wong, S. P.

Significance of Serial C-Reactive Protein Responses in Neonatal Infection and Other Disorders

Massroor Pourcyrous MD1, Henrietta S. Bada MD1, Sheldon B. Korones MD1, Vickie Baselski PhD2, and Seok P. Wong PhD3

1 From the Departments of Pediatrics, Obstetrics and Gynecology, The University of Tennessee, Memphis, Tennessee
2 From the Department of Patohology, The University of Tennessee, Memphis, Tennessee
3 From the Department of Mathematical Sciences, Memphis State University, Memphis, Tennessee

Objective. This study was performed to determine prospectively whether, in the presence of proved or presumed bacterial infection, the sensitivity of serum C-reactive protein (CRP) response could be enhanced by serial rather than single determinations. We also sought to assess CRP responses to clinically identified noninfectious disorders.

Design. The CRP responses of 491 infants on 691 occasions of suspected infection were assessed. CRP levels were measured initially and twice again at 12-hour intervals (rate immunonephelometry). Assessments also included a blood culture, complete blood cell count, and chest radiograph and culture of spinal fluid when appropriate. CRP responses were correlated with four designated clinical groups: (1) positive blood or cerebrospinal fluid cultures (n = 190); (2) negative blood culture-definite infection (necrotizing enterocolitis stages 2 and 3, pneumonia, subcutaneous abscess) (n = 52); (3) negative blood culture-possible infection (antenatal risk factors, meconium aspiration, positive urine group B streptococcus antigen, necrotizing enterocolitis stage 1, febrile infants) (n = 287); and (4) negative blood culture-no infection (respiratory distress syndrome, transient tachypnea of the newborn, patent ductus arteriosus, tissue trauma) (n = 160). Diagnoses were made before CRP results were known.

Results. In all, 187 (27%) of the blood cultures were positive. A single organism was recovered from 174 of these; two organisms from 13. Among the single-organism cultures, 50 (29%) were Gram-negative, 120 (69%) were Gram-positive, and 4 (2%) were budding yeasts. CRP levels were elevated in various groups as follows: in the positive blood culture group (by organism), Gram-negative rods, 92% (46/50); group B streptococcus, 92% (12/13); Staphylococcus aureus, 89% (8/9); group D streptococcus, 71% (10/14); Streptococcus viridans, 60% (6/10); Staphylococcus epidermidis, 55% (40/73). In the negative blood culture-definite infection group, CRP levels were abnormal in 88%; in the negative culture-possible infection group, CRP was elevated in 33%; and in the negative blood culture-no infection group, CRP was elevated in 9%. Serial determinations of CRP resulted in enhanced sensitivity in the positive blood culture group, the negative blood culture-definite infection group, and the negative blood culture-possible infection group. Initial determinations by themselves were inadequatey sensitive. Serial determinations did not enhance sensitivity of the negative blood culture-no infection group. High specificity (91%) is suggested by the low incidence of abnormal CRP levels among infants who were not infected.

Conclusions. These data suggest that it would be appropriate to conduct a cautious, controlled trial to assess the safety of discontinuing antibiotic therapy if three serial CRP measurements are normal and if there are no other clinical factors suggestive of infection. The data also indicate the necessity for serial determinations of CRP for optimal sensitivity.

Key Words: C-reactive protein • neonatal infection • neonatal septicemia

Submitted on July 13, 1992
Accepted on March 29, 1993




This article has been cited by other articles:


Home page
 J. Am. Podiatr. Med. Assoc.Home page
M. S. Judge
Infection and Neuroarthropathy: The Utility of C-reactive Protein as a Screening Tool in the Charcot Foot
J Am Podiatr Med Assoc, January 1, 2008; 98(1): 1 - 6.
[Abstract] [Full Text] [PDF]

Home page
 J Trop PediatrHome page
G. Chowdhary, S. Dutta, and A. Narang
Randomized Controlled Trial of 7-Day vs. 14-Day Antibiotics for Neonatal Sepsis
J Trop Pediatr, December 1, 2006; 52(6): 427 - 432.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
K. K. Hall and J. A. Lyman
Updated Review of Blood Culture Contamination
Clin. Microbiol. Rev., October 1, 2006; 19(4): 788 - 802.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. Pourcyrous, S. B. Korones, W. Yang, T. F. Boulden, and H. S. Bada
C-Reactive Protein in the Diagnosis, Management, and Prognosis of Neonatal Necrotizing Enterocolitis
Pediatrics, November 1, 2005; 116(5): 1064 - 1069.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
D. Kaufman and K. D. Fairchild
Clinical Microbiology of Bacterial and Fungal Sepsis in Very-Low-Birth-Weight Infants
Clin. Microbiol. Rev., July 1, 2004; 17(3): 638 - 680.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
A. R. Franz, K. Bauer, A. Schalk, S. M. Garland, E. D. Bowman, K. Rex, C. Nyholm, M. Norman, A. Bougatef, M. Kron, et al.
Measurement of Interleukin 8 in Combination With C-Reactive Protein Reduced Unnecessary Antibiotic Therapy in Newborn Infants: A Multicenter, Randomized, Controlled Trial
Pediatrics, July 1, 2004; 114(1): 1 - 8.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
P C Ng
Diagnostic markers of infection in neonates
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2004; 89(3): F229 - F235.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Chiesa, A. Panero, J. F. Osborn, A. F. Simonetti, and L. Pacifico
Diagnosis of Neonatal Sepsis: A Clinical and Laboratory Challenge
Clin. Chem., February 1, 2004; 50(2): 279 - 287.
[Full Text] [PDF]

Home page
 NeoReviewsHome page
A. G. S. Philip
Neonatal Meningitis in the New Millennium
NeoReviews, March 1, 2003; 4(3): e73 - 80.
[Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
A. Madan, M. M. Adams, and A. G. S. Philip
Frequency and Timing of Symptoms in Infants Screened for Sepsis: Effectiveness of a Sepsis-Screening Pathway
Clinical Pediatrics, January 1, 2003; 42(1): 11 - 18.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
C. Chiesa, G. Pellegrini, A. Panero, J. F. Osborn, F. Signore, M. Assumma, and L. Pacifico
C-Reactive Protein, Interleukin-6, and Procalcitonin in the Immediate Postnatal Period: Influence of Illness Severity, Risk Status, Antenatal and Perinatal Complications, and Infection
Clin. Chem., January 1, 2003; 49(1): 60 - 68.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
L. G. Rubin, P. J. Sanchez, J. Siegel, G. Levine, L. Saiman, and W. R. Jarvis
Evaluation and Treatment of Neonates With Suspected Late-Onset Sepsis: A Survey of Neonatologists' Practices
Pediatrics, October 1, 2002; 110(4): e42 - 42.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
B. J. Stoll, N. Hansen, A. A. Fanaroff, L. L. Wright, W. A. Carlo, R. A. Ehrenkranz, J. A. Lemons, E. F. Donovan, A. R. Stark, J. E. Tyson, et al.
Changes in Pathogens Causing Early-Onset Sepsis in Very-Low-Birth-Weight Infants
N. Engl. J. Med., July 25, 2002; 347(4): 240 - 247.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Ishibashi, Y. Takemura, H. Ishida, K. Watanabe, and T. Kawai
C-Reactive Protein Kinetics in Newborns: Application of a High-Sensitivity Analytic Method in Its Determination
Clin. Chem., July 1, 2002; 48(7): 1103 - 1106.
[Full Text] [PDF]

Home page
 PediatricsHome page
G. J. Escobar, D.-k. Li, M. A. Armstrong, M. N. Gardner, B. F. Folck, J. E. Verdi, B. Xiong, R. Bergen, and for the Neonatal Infection Study Group
Neonatal Sepsis Workups in Infants >= 2000 Grams at Birth: A Population-Based Study
Pediatrics, August 1, 2000; 106(2): 256 - 263.
[Abstract] [Full Text]

Home page
 PediatricsHome page
A. G. S. Philip and P. C. Mills
Use of C-Reactive Protein in Minimizing Antibiotic Exposure: Experience With Infants Initially Admitted to a Well-Baby Nursery
Pediatrics, July 1, 2000; 106(1): 4e - 4.
[Abstract] [Full Text]

Home page
 PediatricsHome page
A. R. Franz, G. Steinbach, M. Kron, and F. Pohlandt
Reduction of Unnecessary Antibiotic Therapy in Newborn Infants Using Interleukin-8 and C-Reactive Protein as Markers of Bacterial Infections
Pediatrics, September 1, 1999; 104(3): 447 - 453.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
B. S. Dahler-Eriksen, T. Lauritzen, J. F. Lassen, E. D. Lund, and I. Brandslund
Near-Patient Test for C-Reactive Protein in General Practice: Assessment of Clinical, Organizational, and Economic Outcomes
Clin. Chem., April 1, 1999; 45(4): 478 - 485.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
W. E. Benitz, M. Y. Han, A. Madan, and P. Ramachandra
Serial Serum C-Reactive Protein Levels in the Diagnosis of Neonatal Infection
Pediatrics, October 1, 1998; 102(4): e41 - 41.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. Pourcyrous, S. B. Korones, D. Crouse, and H. S. Bada
Interleukin-6, C-Reactive Protein, and Abnormal Cardiorespiratory Responses to Immunization in Premature Infants
Pediatrics, March 1, 1998; 101 (3): e3 - e3.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
P W Fowlie and B Schmidt
Diagnostic tests for bacterial infection from birth to 90 days---a systematic review
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 1998; 78(2): 92F - 98.
[Abstract] [Full Text]

Home page
 CLIN PEDIATRHome page
S. R. Allen
Management of Asymptomatic Term Neonates Whose Mothers Received Intrapartum Antibiotics--Part 2: Diagnostic Tests and Management Strategies
Clinical Pediatrics, November 1, 1997; 36(11): 617 - 624.
[Abstract] [PDF]

Home page
 PediatricsHome page
M. J. Grella;, S. Ehl, and F. Pohlandt
C-Reactive Protein to Determine the Duration of Antibiotic Therapy in Infants With Suspected Sepsis
Pediatrics, November 1, 1997; 100(5): 900 - 900.
[Full Text]

Home page
 PediatricsHome page
S. Ehl, B. Gering, P. Bartmann, J. Hogel, and F. Pohlandt
C-Reactive Protein Is a Useful Marker for Guiding Duration of Antibiotic Therapy in Suspected Neonatal Bacterial Infection
Pediatrics, February 1, 1997; 99(2): 216 - 221.
[Abstract] [Full Text] [PDF]